We are scholars, students, and activists working for a biotechnology that places the health and welfare of people and the natural environment above financial interests.
We analyze, speak, and publish on the social and environmental impacts of biotechnological developments. Areas of interest include synthetic biology, genetic, reproductive, and "designer baby" technologies, human egg harvesting, cloning research, human-animal hybrid research, biotech patenting, and genetic privacy.
AHB examines the social, political, and economic conditions giving rise to human genetic engineering and genetically modified organisms (GMOs), recognizing that human commodification and the commodification of the natural environment are products of the same social processes.
We invite you to begin by checking out"AHB 101" for a thumbnail sketch, recommended readings, and short videos concerning the cultural politics of biotechnological development. Throughout the site look for AHB NOTES in red for explanations of terminology, concepts, or technologies. A red AHB QUERY offers a challenge or reflection.
Please bookmark our site. Tell your Facebook or other social networking friends and colleagues about AHB. And be sure to visit GET ACTIVE!for suggestions on how you can help work for a humane biotechnology.
Rabbi Michael Lerner Margaret F. Lynch, Ph.D. Stuart A. Newman, Ph.D. Marsha Saxton, Ph.D. Stephen Shmanske, Ph.D. Sheila R. Tully, Ph.D. Casey Walker Peter J. Whitehouse, M.D., Ph.D. Malcolm Zaretsky, Ph.D, MPH
AHB NOTE: See also Newman's, "My attempt to patent a human-animal chimera," where he relates that Philip Leder, Chair of the Genetics Department, Harvard Medical School stated in 1998 that, “[t]he creation of chimeras is an outlandish undertaking. No one is trying to do it at present, certainly not involving human beings.” Such a comment contrasts starkly with Great Britain's recent green-light for creating human-animal embryos and offers a dramatic example, once again, of biotech's slippery ethical slope.